[Ip-health] Press links on OTA and lack of Bayh-Dole safeguards in COVID-contracts
claire.cassedy at keionline.org
Thu Jul 2 11:45:13 PDT 2020
Also see this article from April 3rd on the issue:
Alicia Mundy. “How Big Pharma Is Getting Ready To Blackmail Americans”.
DCReport. April 3, 2020.
Knowledge Ecology International
1621 Connecticut Avenue NW
Washington, DC 20009
On Thu, Jul 2, 2020 at 11:31 AM Claire Cassedy <claire.cassedy at keionline.org>
> Below are links to some of the press coverage on the Other Transaction
> Authority agreement issue and the COVID-related OTAs.
> Christopher Rowland. "Trump administration makes it easier for drugmakers
> to profit from publicly funded coronavirus drugs, advocates say."
> Washington Post. July 1, 2020.
> Bob Herman. “Federal government weakened its march-in rights for
> coronavirus drugs.” Axios. July 1, 2020.
> Sharon Lerner. “The Trump Administration is waiving the public’s right to
> affordable coronavirus treatments.” The Intercept. July 1, 2020.
> Ed Silverman and Nicholas Florko. “Some U.S. government contracts for
> Covid-19 research could skirt affordable pricing laws.” STAT. July 1, 2020.
> Jonathon Gardner. "Federal coronavirus contracts dodge pricing oversight,
> advocacy group says." BioPharma Dive. July 1, 2020.
> KEI's press advisory available here:
> Claire Cassedy
> Knowledge Ecology International
> 1621 Connecticut Avenue NW
> Suite 500
> Washington, DC 20009
> Tel.: 1.202.332.2670
More information about the Ip-health